We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

350 hedge funds and large institutions have $5.48B invested in Nektar Therapeutics in 2019 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 140 increasing their positions, 109 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 31

28% more repeat investments, than reductions

Existing positions increased: 140 | Existing positions reduced: 109

2% more funds holding

Funds holding: 343 → 350 (+7)

1% more capital invested

Capital invested by funds: $5.41B → $5.48B (+$66.7M)

0.11% less ownership

Funds ownership: 6.36% → 6.24% (-0.11%)

42% less call options, than puts

Call options by funds: $28.1M | Put options by funds: $48.5M

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
350
Holders Change
+7
Holders Change %
+2.04%
% of All Funds
7.57%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
41
Increased
140
Reduced
109
Closed
31
Calls
$28.1M
Puts
$48.5M
Net Calls
-$20.4M
Net Calls Change
-$59.8M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$87.7M
2
BB
BB Biotech
Switzerland
+$25.3M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$16.7M
4
JP Morgan Chase
JP Morgan Chase
New York
+$16.2M
5
State Street
State Street
Massachusetts
+$12.2M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$219M
2
Morgan Stanley
Morgan Stanley
New York
-$22.7M
3
BlackRock
BlackRock
New York
-$18.3M
4
Deutsche Bank
Deutsche Bank
Germany
-$16.3M
5
Voloridge Investment Management
Voloridge Investment Management
Florida
-$10.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
326
Covington Capital Management
California
$3K – – –
EARNEST Partners
327
EARNEST Partners
Georgia
$3K – – –
NSIM
328
North Star Investment Management
Illinois
$3K – – –
PCP
329
Proficio Capital Partners
Massachusetts
$3K – – –
FMII
330
Farmers & Merchants Investments Inc
Nebraska
$3K +$1.19K +2 +50%
LWM
331
Lenox Wealth Management
Ohio
$3K +$2.96K +5 New
SWM
332
SeaCrest Wealth Management
New York
$2K -$11.9K -20 -87%
PFBT
333
Parkside Financial Bank & Trust
Missouri
$2K +$593 +1 +50%
FC
334
Ferris Capital
Massachusetts
$2K +$1.78K +3 New
CIAS
335
Capital Investment Advisory Services
North Carolina
$2K +$2.37K +4 New
Carson Wealth (CWM LLC)
336
Carson Wealth (CWM LLC)
Nebraska
$2K +$2.37K +4 +133%
SWA
337
Sutton Wealth Advisors
Florida
$1.01K – – –
CBOA
338
Commonwealth Bank of Australia
Australia
$1K -$593 -1 -33%
AIA
339
Alera Investment Advisors
Illinois
$1K – – –
WCM
340
Whitener Capital Management
North Carolina
$1K – – –
TCOV
341
Trust Company of Vermont
Vermont
$1K +$593 +1 New
CFG
342
Citizens Financial Group
Rhode Island
$1K +$1.19K +2 New
CI
343
CX Institutional
Indiana
$1K +$1.19K +2 New
FGAM
344
Financial Gravity Asset Management
Texas
$1K +$1.19K +2 New
RWML
345
RAFFA WEALTH MANAGEMENT, LLC
District of Columbia
$571 – – –
RCAG
346
Rehmann Capital Advisory Group
Michigan
$168 – – –
GT
347
Glenmede Trust
Pennsylvania
$88 – – –
Voloridge Investment Management
348
Voloridge Investment Management
Florida
– -$10.6M -21,576 Closed
GAM
349
Gotham Asset Management
New York
– -$5.95M -12,073 Closed
Squarepoint
350
Squarepoint
New York
– -$4.88M -9,899 Closed
12 13
14
15 16

NKTR Hedge Fund Activity: Q1 2019 in Review

350 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q1 2019, worth a combined $5.48B — up 1.2% from $5.41B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new NKTR positions and 31 closed out — a net gain of 10 holders — while 140 added to existing stakes and 109 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $87.7M. The largest seller was Fidelity Investments, cutting an estimated $219M.

  • 350 institutional investors held Nektar Therapeutics (NKTR) as of Q1 2019, up from 343 in Q4 2018.
  • Funds reported $5.48B of Nektar Therapeutics stock for Q1 2019, up 1.2% quarter-over-quarter.
  • 41 funds opened new Nektar Therapeutics positions in Q1 2019 and 31 closed out, a net change of +10 holders.
  • The largest Nektar Therapeutics buyer in Q1 2019 was Wellington Management Group, an estimated $87.7M added.
  • The largest Nektar Therapeutics seller in Q1 2019 was Fidelity Investments, an estimated $219M sold.

Based on aggregated 13F filings for Q1 2019.